Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
Stephen J. Thomas, Edson Duarte Moreira, Nicholas Kitchin, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1761-1773
Open Access | Times Cited: 888

Showing 1-25 of 888 citing articles:

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
Sara Y. Tartof, Jeff Slezak, Heidi Fischer, et al.
The Lancet (2021) Vol. 398, Iss. 10309, pp. 1407-1416
Open Access | Times Cited: 1166
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Waning Immunity after the BNT162b2 Vaccine in Israel
Yair Goldberg, Micha Mandel, Yinon M. Bar-On, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 669
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 19, pp. 1774-1785
Open Access | Times Cited: 571
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly, Patrick Tang, Mohammad R. Hasan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 553
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
Emmanuel B. Walter, Kawsar R. Talaat, Charu Sabharwal, et al.
New England Journal of Medicine (2021) Vol. 386, Iss. 1, pp. 35-46
Open Access | Times Cited: 543
The clinical progress of mRNA vaccines and immunotherapies
Ann Barbier, Allen Yujie Jiang, Peng Zhang, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 6, pp. 840-854
Open Access | Times Cited: 468
Humoral and cellular immune memory to four COVID-19 vaccines
Zeli Zhang, José Mateus, Camila H. Coelho, et al.
Cell (2022) Vol. 185, Iss. 14, pp. 2434-2451.e17
Open Access | Times Cited: 444
Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults
Ben Killingley, Alex Mann, Mariya Kalinova, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1031-1041
Open Access | Times Cited: 422
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, et al.
Nature Medicine (2021) Vol. 27, Iss. 12, pp. 2136-2143
Open Access | Times Cited: 416
Advances in COVID-19 mRNA vaccine development
Enyue Fang, Xiaohui Liu, Miao Li, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 392
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Ann R. Falsey, Robert W. Frenck, Edward E. Walsh, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 17, pp. 1627-1629
Open Access | Times Cited: 386
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e52-e61
Open Access | Times Cited: 340
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Qiao Liu, Chenyuan Qin, Min Liu, et al.
Infectious Diseases of Poverty (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 311
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
Edson Duarte Moreira, Nicholas Kitchin, Xia Xu, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 20, pp. 1910-1921
Open Access | Times Cited: 305
Covid-19 Vaccine Effectiveness in New York State
Eli S. Rosenberg, Vajeera Dorabawila, Delia Easton, et al.
New England Journal of Medicine (2021) Vol. 386, Iss. 2, pp. 116-127
Open Access | Times Cited: 300
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells
José Mateus, Jennifer M. Dan, Zeli Zhang, et al.
Science (2021) Vol. 374, Iss. 6566
Open Access | Times Cited: 290
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
Timothy A. Bates, Savannah K. McBride, Hans C. Leier, et al.
Science Immunology (2022) Vol. 7, Iss. 68
Open Access | Times Cited: 279
Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet (2022) Vol. 399, Iss. 10327, pp. 814-823
Open Access | Times Cited: 278
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Priyal Mistry, Fatima Barmania, Juanita Mellet, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 275
Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
Peter Nordström, Marcel Ballin, Anna Nordström
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 6, pp. 781-790
Open Access | Times Cited: 258
Efficacy and safety of COVID-19 vaccines
Carolina Graña, Lina Ghosn, Theodoros Evrenoglou, et al.
Cochrane library (2022) Vol. 2023, Iss. 3
Open Access | Times Cited: 254
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 241
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
Page 1 - Next Page

Scroll to top